DE SHAW & CO

Below please find a 13F analysis report for DE Shaw & Co for Q1 2009. 13F analyses are reports that fund managers with over $100M are required to submit to the SEC, they are publicly available and these reports provide us with some insights on what some hedge fund managers have been investing in.
Founded in 1988, the D. E. Shaw group is a global investment and technology development firm with approximately $35 billion in aggregate investment capital and offices in North America, Europe, and Asia.
• (ABC) Amerisourcebergen Corp
• (ABII) Abraxis Bioscience
• (APC) Anadarco Petroleum Group
• (APOL) Apollo Group
• (BIIB) Biogen Idec
• (DGX) Quest Diagonistics
• (ENDP) Endo Pharmacueticals holdings
• (FCX) Freeport MCmoran Copper & Gold
• (INTC) Intel Corp
• (MYL) Mylan Laboratories
• (OC) Owens Corning
• (ORCL) Oracle Corp
• (PFE) Pfizer
• (VRTX) Vertex Pharmacueticals
• (WCRX) Warner Chilcott Ltd

The top 5 highest performing equities which for DE Shaw & Co held as of this 13F filing include (OC), (ORCL), (DGX), (VRTX) and (WCRX)

For more information on for DE Shaw & Co please see the HedgeFundBlogger.com. Hedge Fund Tracker Profile on for DE Shaw & Co by clicking here.
Related to: DE Shaw & Co
- Top 5 Hedge Fund Marketing Strategies | MP3 Audio Download
- Hedge Fund Marketing Tools
- 5 Unique Hedge Fund Marketing Tactics (1 of 5)
- 5 Unique Hedge Fund Marketing Tactics (2 of 5)
- 5 Unique Hedge Fund Marketing Tactics (3 of 5)
- Marketing to Institutional Investors
- Hedge Fund Pitch Book Marketing Materials
- Hedge Fund Business Plan | Plans For Growth
- Hedge Fund PowerPoint Improvement Tips
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.